HUANG Xuan-San Yigan the treatment of chronic hepatitis B.docVIP

 PAGE \* MERGEFORMAT 2 HUANG Xuan-San Yigan the treatment of chronic hepatitis B [Abstract] Objective: To evaluate the treatment of chronic hepatitis B HUANG Xuan-Yi Gan San clinical effect. Methods: I out-patient and hospitalization of 80 patients with mild and moderate chronic hepatitis B patients, according to odd and even number of treatment group of 40 patients were randomly divided into treatment and control group of 40 patients; treatment group HUANG Xuan-Yi Gan San meal 1 / 2 h oral, each 9 g, 3 times / day, control group with the α -1b interferon 5 million U, 1 times / day, intramuscular injection, 20 d later changed to every other day a second course of treatment both in March. Results: The total effective rate was 62.5% in the control group, the total effective rate was 65.0%, two groups of clinical efficacy and HBeAg and HBV DNA negative conversion and other indicators were similar. Tip HUANG Xuan San Yigan has good anti-virus and hepatoprotective effects. Conclusion: HUANG Xuan-Yi Gan San safe and effective treatment of chronic hepatitis B, and low-cost, side effects is small, worthy of clinical application. [Keywords:] HUANG Xuan-Yi Gan San; chronic hepatitis B; interferon I Branch in January 2004 to December 2006 HUANG Xuan-Yi Gan San with the treatment of chronic hepatitis B, to achieve better efficacy, are reported below. 1 Data and methods 1.1 The clinical data of 80 patients with chronic hepatitis B patients for my Section from January 2004 to December 2006 out-patient and ward for treatment of chronic hepatitis B patients. Diagnostic 2000 Xi’an 10th National Conference on Viral Hepatitis and Liver Disease revised diagnostic criteria of chronic hepatitis B [1]. 80 cases of patients positive for HBsAg and HBeAg All (ELISA method), HBV DNA levels (viral load) ≥ 105 cp / mL, serum alanine aminotransferase (ALT) increased 2 ~ 10 times. Male 64 cases, female 16 cases; aged 20 to 60 years, mean 35 years of age; duration of 0.5 to 15 years, an